Janssen Korea and J&J Korea to seek co-marketing from next year

Janssen Korea and Johnson & Johnson Korea has announced that they would co-market Tylenol (acetaminophen) and Nizoral (ketoconazole) in the domestic market from January 1, next year, as part of efforts to maximize individual promotion effects.

According to their marketing plan, Janssen Korea will assume the marketing for ethical products, such as Tylenol ER and Nizoral in larger pack.

J&...